Naveen Karkada

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Cervical Cancer Screening

Top Venues

Human vaccines & immunotherapeutics

Expert review of vaccines

Infectious diseases and therapy

GlaxoSmithKline Biologicals SA

Bangalore University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Biologicals SA Jul 01 2008

Belgium

Lead Statistician :: Biostatistics and Statistical Programming

Education History

Bangalore University Jun 01 2006 - Jun 30 2008

India

MSC :: Statistics

Publications

Shang-Ying Hu, Xiao-Qian Xu, Fengcai Zhu, Ying Hong, Yuemei Hu, Xun Zhang, Qinjing Pan, Wenhua Zhang, Chengfu Zhang, Xiaoping Yang, Jiaxi Yu, Jiahong Zhu, Yejiang Zhu, Feng Chen, Shuang Zhao, Naveen Karkada, Haiwen Tang, Dan Bi, Frank Struyf, Fanghui Zhao
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial. Human vaccines & immunotherapeutics 17 (4) (2020)
Ashish Agrawal, Shafi Kolhapure, Anar Andani, Martin O C Ota, Selim Badur, Naveen Karkada, Monjori Mitra
Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children. Infectious diseases and therapy 9 (4) (2020)
Tino F Schwarz, Li-Min Huang, Alejandra Valencia, Falko Panzer, Cheng-Hsun Chiu, Annabelle Decreux, Sylviane Poncelet, Naveen Karkada, Nicolas Folschweiller, Lan Lin, Gary Dubin, Frank Struyf
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human vaccines & immunotherapeutics 15 (7-8) (2019)
Martin Ryser, Valérie Berlaimont, Naveen Karkada, Attila Mihalyi, Rino Rappuoli, Robbert van der Most
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types. Expert review of vaccines 18 (3) (2019)